Skip to main content
Top
Published in: BMC Urology 1/2022

Open Access 01-12-2022 | Fatty Liver | Research

Prevalence and risk factors of kidney stone disease in population aged 40–70 years old in Kharameh cohort study: a cross-sectional population-based study in southern Iran

Authors: Leila Moftakhar, Fatemeh Jafari, Masoumeh Ghoddusi Johari, Ramin Rezaeianzadeh, Seyed Vahid Hosseini, Abbas Rezaianzadeh

Published in: BMC Urology | Issue 1/2022

Login to get access

Abstract

Background

Kidney stone is the major cause of morbidity, and its prevalence is increasing in the world. This study aimed to assess the prevalence and risk factors of kidney stone in the adult population of southern Iran based on the data of the Kharameh Cohort Study.

Methods

This cross-sectional study was conducted on 10,663 individuals aged 40–70 years old, using the baseline data of Kharamah cohort study, which started in 2014. Among all participants, 2251 individuals had a history of kidney stone. The participants’ demographic characteristics, behavioral habits, and the history of underlying diseases were investigated. The crude and Age Standardized Prevalence Rate of kidney stones was calculated. Also, logistic regression was used to identify the predictors of kidney stone. To check the goodness of fit index of the model, we used the Hosmer–Lemeshow test. All analyses were performed in STATA software.

Results

The prevalence of kidney stone was estimated 21.11%. Also, the Age Standardized Prevalence Rate in men and women was calculated 24.3% and 18.7%, respectively. The mean age of the participants was 52.15 years. Higher prevalence of kidney stone was seen in women aged 40–50 years (40.47%, p = 0.0001) and moderate level of social economic status (31.47%, p = 0.03), men with overweight (44.69%, p < 0.0001) and those in a very high level of social economic status (35.75%, p = 0.001). The results of multiple logistic regression showed that the chance of having kidney stone was 1.17 times higher in diabetic individuals, 1.43 times higher in hypertensive individuals, 2.21 times higher in individuals with fatty liver, and 1.35 times higher in individuals with overweight. The level of socio economic status, male sex, and age were the other factors related to kidney stone.

Conclusion

In this study, underlying diseases such as fatty liver, diabetes, and hypertension as well as age, male sex, overweight, and high social economic status were identified as important risk factors for kidney stone. Therefore, identifying individuals at risk of kidney stone and providing the necessary training can greatly help to reduce this disease. However, health policymakers should prepare preventive strategies to reduce the occurrence of kidney stone.
Literature
1.
go back to reference Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12(2–3):e86. Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12(2–3):e86.
2.
go back to reference Nikpay S, Moradi K, Azami M, Babashahi M, Otaghi M, Borji M. Frequency of kidney stone different compositions in patients referred to a lithotripsy center in Ilam. West of Iran j ped nephrol. 2016;4(3):102–7. Nikpay S, Moradi K, Azami M, Babashahi M, Otaghi M, Borji M. Frequency of kidney stone different compositions in patients referred to a lithotripsy center in Ilam. West of Iran j ped nephrol. 2016;4(3):102–7.
3.
go back to reference Aune D, Mahamat-Saleh Y, Norat T, Riboli E. Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2018;33(11):1033–47.CrossRef Aune D, Mahamat-Saleh Y, Norat T, Riboli E. Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2018;33(11):1033–47.CrossRef
4.
go back to reference Ma R-h, et al. Systemic analysis of urinary stones from the Northern, Eastern, Central, Southern and Southwest China by a multi-center study. BMC Urol. 2018;18(1):1–10.CrossRef Ma R-h, et al. Systemic analysis of urinary stones from the Northern, Eastern, Central, Southern and Southwest China by a multi-center study. BMC Urol. 2018;18(1):1–10.CrossRef
6.
go back to reference Tadayyon F, Sabbagh M. The prevalence of kidney stone different composition in patients referred to the lithotripsy wards. J Isfahan Med Sch. 2011;28:122. Tadayyon F, Sabbagh M. The prevalence of kidney stone different composition in patients referred to the lithotripsy wards. J Isfahan Med Sch. 2011;28:122.
7.
go back to reference van de Pol JA, van den Brandt PA, Schouten LJ. Kidney stones and the risk of renal cell carcinoma and upper tract urothelial carcinoma: the Netherlands cohort study. Br J Cancer. 2019;120(3):368–74.CrossRef van de Pol JA, van den Brandt PA, Schouten LJ. Kidney stones and the risk of renal cell carcinoma and upper tract urothelial carcinoma: the Netherlands cohort study. Br J Cancer. 2019;120(3):368–74.CrossRef
8.
go back to reference Turney BW, Appleby PN, Reynard JM, Noble JG, Key TJ, Allen NE. Diet and risk of kidney stones in the Oxford cohort of the European prospective investigation into cancer and nutrition (EPIC). Eur J Epidemiol. 2014;29(5):363–9.CrossRef Turney BW, Appleby PN, Reynard JM, Noble JG, Key TJ, Allen NE. Diet and risk of kidney stones in the Oxford cohort of the European prospective investigation into cancer and nutrition (EPIC). Eur J Epidemiol. 2014;29(5):363–9.CrossRef
9.
go back to reference Scales CD Jr, Smith AC, Hanley JM, Saigal CS, Project UDiA. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160–5.CrossRef Scales CD Jr, Smith AC, Hanley JM, Saigal CS, Project UDiA. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160–5.CrossRef
10.
go back to reference Littlejohns TJ, Neal NL, Bradbury KE, Heers H, Allen NE, Turney BW. Fluid intake and dietary factors and the risk of incident kidney stones in UK biobank: a population-based prospective cohort study. Eur Urol Focus. 2020;6(4):752–61.CrossRef Littlejohns TJ, Neal NL, Bradbury KE, Heers H, Allen NE, Turney BW. Fluid intake and dietary factors and the risk of incident kidney stones in UK biobank: a population-based prospective cohort study. Eur Urol Focus. 2020;6(4):752–61.CrossRef
11.
go back to reference Sigurjonsdottir VK, Runolfsdottir HL, Indridason OS, Palsson R, Edvardsson VO. Impact of nephrolithiasis on kidney function. BMC nephrol. 2015;16(1):1–7.CrossRef Sigurjonsdottir VK, Runolfsdottir HL, Indridason OS, Palsson R, Edvardsson VO. Impact of nephrolithiasis on kidney function. BMC nephrol. 2015;16(1):1–7.CrossRef
12.
go back to reference El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ, et al. Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol. 2012;7(9):1409–15.CrossRef El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ, et al. Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol. 2012;7(9):1409–15.CrossRef
13.
go back to reference Rule AD, Roger VL, Melton LJ, Bergstralh EJ, Li X, Peyser PA, et al. Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol. 2010;21(10):1641–4.CrossRef Rule AD, Roger VL, Melton LJ, Bergstralh EJ, Li X, Peyser PA, et al. Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol. 2010;21(10):1641–4.CrossRef
14.
go back to reference Alelign T, Petros B. Kidney stone disease: an update on current concepts. Adv Urol. 2018;2018. Alelign T, Petros B. Kidney stone disease: an update on current concepts. Adv Urol. 2018;2018.
15.
go back to reference Penniston KL, Nakada SY. Development of an instrument to assess the health related quality of life of kidney stone formers. J Urol. 2013;189(3):921–30.CrossRef Penniston KL, Nakada SY. Development of an instrument to assess the health related quality of life of kidney stone formers. J Urol. 2013;189(3):921–30.CrossRef
16.
go back to reference Jones P, Karim Sulaiman S, Gamage KN, Tokas T, Jamnadass E, Somani BK. Do lifestyle factors including smoking, alcohol, and exercise impact your risk of developing kidney stone disease? Outcomes of a systematic review. Scand J Urol. 2021;35(1):1–7. Jones P, Karim Sulaiman S, Gamage KN, Tokas T, Jamnadass E, Somani BK. Do lifestyle factors including smoking, alcohol, and exercise impact your risk of developing kidney stone disease? Outcomes of a systematic review. Scand J Urol. 2021;35(1):1–7.
17.
go back to reference Antonelli JA, Maalouf NM, Pearle MS, Lotan Y. Use of the national health and nutrition examination survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. Eur Urol. 2014;66(4):724–9.CrossRef Antonelli JA, Maalouf NM, Pearle MS, Lotan Y. Use of the national health and nutrition examination survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. Eur Urol. 2014;66(4):724–9.CrossRef
18.
go back to reference Edvardsson VO, Indridason OS, Haraldsson G, Kjartansson O, Palsson R. Temporal trends in the incidence of kidney stone disease. Kidney Int. 2013;83(1):146–52.CrossRef Edvardsson VO, Indridason OS, Haraldsson G, Kjartansson O, Palsson R. Temporal trends in the incidence of kidney stone disease. Kidney Int. 2013;83(1):146–52.CrossRef
19.
go back to reference Moniruzzaman M, Zaman MM, Islalm M, Ahasan H, Kabir H, Yasmin R. Physical activity levels in Bangladeshi adults: results from STEPS survey 2010. Public Health. 2016;137:131–8.CrossRef Moniruzzaman M, Zaman MM, Islalm M, Ahasan H, Kabir H, Yasmin R. Physical activity levels in Bangladeshi adults: results from STEPS survey 2010. Public Health. 2016;137:131–8.CrossRef
20.
go back to reference Swets JA. Measuring the accuracy of diagnostic systems. Sci. 1988;240(4857):1285–93.CrossRef Swets JA. Measuring the accuracy of diagnostic systems. Sci. 1988;240(4857):1285–93.CrossRef
21.
go back to reference Stamatelou KK, Francis ME, Jones CA, Nyberg LM Jr, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003;63(5):1817–23.CrossRef Stamatelou KK, Francis ME, Jones CA, Nyberg LM Jr, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003;63(5):1817–23.CrossRef
22.
go back to reference Wang W, Fan J, Huang G, Li J, Zhu X, Tian Y, et al. Prevalence of kidney stones in mainland China: a systematic review. Sci Rep. 2017;7(1):1–9. Wang W, Fan J, Huang G, Li J, Zhu X, Tian Y, et al. Prevalence of kidney stones in mainland China: a systematic review. Sci Rep. 2017;7(1):1–9.
23.
go back to reference Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJUI Compass. 2017;120(1):109–16.CrossRef Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJUI Compass. 2017;120(1):109–16.CrossRef
24.
go back to reference Ahmad F, Nada MO, Farid AB, Haleem M, Razack S. Epidemiology of urolithiasis with emphasis on ultrasound detection: a retrospective analysis of 5371 cases in Saudi Arabia. Saudi J Kidney Dis Transpl. 2015;26(2):386.CrossRef Ahmad F, Nada MO, Farid AB, Haleem M, Razack S. Epidemiology of urolithiasis with emphasis on ultrasound detection: a retrospective analysis of 5371 cases in Saudi Arabia. Saudi J Kidney Dis Transpl. 2015;26(2):386.CrossRef
25.
go back to reference Bihl G, Meyers A. Recurrent renal stone disease—advances in pathogenesis and clinical management. The Lancet. 2001;358(9282):651–6.CrossRef Bihl G, Meyers A. Recurrent renal stone disease—advances in pathogenesis and clinical management. The Lancet. 2001;358(9282):651–6.CrossRef
26.
go back to reference Hesse A, Brändle E, Wilbert D, Köhrmann K-U, Alken P. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol. 2003;44(6):709–13.CrossRef Hesse A, Brändle E, Wilbert D, Köhrmann K-U, Alken P. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol. 2003;44(6):709–13.CrossRef
27.
go back to reference Indridason OS, Birgisson S, Edvardsson VO, Sigvaldason H, Sigfusson N, Palsson R. Epidemiology of kidney stones in Iceland a population-based study. Scand J Urol. 2006;40(3):215–20.CrossRef Indridason OS, Birgisson S, Edvardsson VO, Sigvaldason H, Sigfusson N, Palsson R. Epidemiology of kidney stones in Iceland a population-based study. Scand J Urol. 2006;40(3):215–20.CrossRef
28.
go back to reference Khalili P, Jamali Z, Sadeghi T, Esmaeili-Nadimi A, Mohamadi M, Moghadam-Ahmadi A, et al. Risk factors of kidney stone disease: a cross-sectional study in the southeast of Iran. BMC Urol. 2021;21(1):1–8.CrossRef Khalili P, Jamali Z, Sadeghi T, Esmaeili-Nadimi A, Mohamadi M, Moghadam-Ahmadi A, et al. Risk factors of kidney stone disease: a cross-sectional study in the southeast of Iran. BMC Urol. 2021;21(1):1–8.CrossRef
29.
go back to reference Shirazi F, Shahpourian F, Khachian A, Hosseini F, Heidari S, Sanjari M. Personal characteristics and urinary stones. hkjn. 2009;11(1):14–9. Shirazi F, Shahpourian F, Khachian A, Hosseini F, Heidari S, Sanjari M. Personal characteristics and urinary stones. hkjn. 2009;11(1):14–9.
30.
go back to reference Safarinejad MR. Adult urolithiasis in a population-based study in Iran: prevalence, incidence, and associated risk factors. Urol Res. 2007;35(2):73–82.CrossRef Safarinejad MR. Adult urolithiasis in a population-based study in Iran: prevalence, incidence, and associated risk factors. Urol Res. 2007;35(2):73–82.CrossRef
31.
go back to reference Javed A, Adeel A, Nand K, Shafique UR. JLUMHS. 2013. Javed A, Adeel A, Nand K, Shafique UR. JLUMHS. 2013.
32.
go back to reference Khan A. Prevalence, pathophysiological mechanisms and factors affecting urolithiasis. Int Urol Nephrol. 2018;50(5):799–806.CrossRef Khan A. Prevalence, pathophysiological mechanisms and factors affecting urolithiasis. Int Urol Nephrol. 2018;50(5):799–806.CrossRef
33.
go back to reference Kale SS, Ghole VS, Pawar N, Jagtap DV. Inter-annual variability of urolithiasis epidemic from semi-arid part of Deccan Volcanic Province, India: climatic and hydrogeochemical perspectives. IJEHR. 2014;24(3):278–89. Kale SS, Ghole VS, Pawar N, Jagtap DV. Inter-annual variability of urolithiasis epidemic from semi-arid part of Deccan Volcanic Province, India: climatic and hydrogeochemical perspectives. IJEHR. 2014;24(3):278–89.
34.
go back to reference Iguchi M, Umekawa T, Katoh Y, Kohri K, Kurita T. Prevalence of urolithiasis in Kaizuka City, Japan—an epidemiologic study of urinary stones. Int J Urol. 1996;3(3):175–9.CrossRef Iguchi M, Umekawa T, Katoh Y, Kohri K, Kurita T. Prevalence of urolithiasis in Kaizuka City, Japan—an epidemiologic study of urinary stones. Int J Urol. 1996;3(3):175–9.CrossRef
35.
go back to reference Curhan GC. Epidemiology of stone disease. Urol Clin North Am. 2007;34(3):287–93.CrossRef Curhan GC. Epidemiology of stone disease. Urol Clin North Am. 2007;34(3):287–93.CrossRef
36.
go back to reference Inci M, Demirtas A, Sarli B, Akinsal E, Baydilli N. Association between body mass index, lipid profiles, and types of urinary stones. Ren Fail. 2012;34(9):1140–3.CrossRef Inci M, Demirtas A, Sarli B, Akinsal E, Baydilli N. Association between body mass index, lipid profiles, and types of urinary stones. Ren Fail. 2012;34(9):1140–3.CrossRef
37.
go back to reference Nowfar S, Palazzi-Churas K, Chang DC, Sur RL. The relationship of obesity and gender prevalence changes in United States inpatient nephrolithiasis. Urol. 2011;78(5):1029–33.CrossRef Nowfar S, Palazzi-Churas K, Chang DC, Sur RL. The relationship of obesity and gender prevalence changes in United States inpatient nephrolithiasis. Urol. 2011;78(5):1029–33.CrossRef
38.
go back to reference Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293(4):455–62.CrossRef Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293(4):455–62.CrossRef
39.
go back to reference Shahidi S, Dolatkhah S, Mortazavi M, Atapour A, Aghaaliakbari F, Meamar R, et al. An epidemiological survey on kidney stones and related risk factors in the iranian community. Acta Med Iran. 2022;60(5):307. Shahidi S, Dolatkhah S, Mortazavi M, Atapour A, Aghaaliakbari F, Meamar R, et al. An epidemiological survey on kidney stones and related risk factors in the iranian community. Acta Med Iran. 2022;60(5):307.
40.
go back to reference Eisner BH, Eisenberg ML, Stoller ML. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis. Urol. 2010;75(6):1289–93.CrossRef Eisner BH, Eisenberg ML, Stoller ML. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis. Urol. 2010;75(6):1289–93.CrossRef
41.
go back to reference Lee Y-H, Huang W-C, Tsai J-Y, Lu C-M, Chen W-C, Lee M-H, et al. Urol Int. 2002;68(3):172–7.CrossRef Lee Y-H, Huang W-C, Tsai J-Y, Lu C-M, Chen W-C, Lee M-H, et al. Urol Int. 2002;68(3):172–7.CrossRef
42.
go back to reference Yasui T, Iguchi M, Suzuki S, Kohri KJU. Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urol. 2008;71(2):209–13.CrossRef Yasui T, Iguchi M, Suzuki S, Kohri KJU. Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urol. 2008;71(2):209–13.CrossRef
43.
go back to reference Muslumanoglu AY, Binbay M, Yuruk E, Akman T, Tepeler A, Esen T, et al. Updated epidemiologic study of urolithiasis in Turkey. I: Changing characteristics of urolithiasis. Urol Res. 2011;39(4):309–14.CrossRef Muslumanoglu AY, Binbay M, Yuruk E, Akman T, Tepeler A, Esen T, et al. Updated epidemiologic study of urolithiasis in Turkey. I: Changing characteristics of urolithiasis. Urol Res. 2011;39(4):309–14.CrossRef
44.
go back to reference Memon A, Anwar K, Orakzai N, Ather MH, Biyabani SR, Nasir AR, et al. Epidemiology of stone disease in Pakistan. Urolithiasis: Springer; 2012. p. 21–38. Memon A, Anwar K, Orakzai N, Ather MH, Biyabani SR, Nasir AR, et al. Epidemiology of stone disease in Pakistan. Urolithiasis: Springer; 2012. p. 21–38.
45.
go back to reference Sohgaura A, Bigoniya P. A review on epidemiology and etiology of renal stone. Am J Drug Discov Dev. 2017;7(2):54–62.CrossRef Sohgaura A, Bigoniya P. A review on epidemiology and etiology of renal stone. Am J Drug Discov Dev. 2017;7(2):54–62.CrossRef
46.
go back to reference Chung S-D, Chen Y-K, Lin H-C. Increased risk of diabetes in patients with urinary calculi: a 5-year followup study. J Urol. 2011;186(5):1888–93.CrossRef Chung S-D, Chen Y-K, Lin H-C. Increased risk of diabetes in patients with urinary calculi: a 5-year followup study. J Urol. 2011;186(5):1888–93.CrossRef
47.
go back to reference Weinberg AE, Patel CJ, Chertow GM, Leppert JT. Diabetic severity and risk of kidney stone disease. Eur Urol. 2014;65(1):242–7.CrossRef Weinberg AE, Patel CJ, Chertow GM, Leppert JT. Diabetic severity and risk of kidney stone disease. Eur Urol. 2014;65(1):242–7.CrossRef
48.
go back to reference Kabeya Y, Kato K, Tomita M, Katsuki T, Oikawa Y, Shimada A, et al. Associations of insulin resistance and glycemic control with the risk of kidney stones. Intern Med. 2012;51(7):699–705.CrossRef Kabeya Y, Kato K, Tomita M, Katsuki T, Oikawa Y, Shimada A, et al. Associations of insulin resistance and glycemic control with the risk of kidney stones. Intern Med. 2012;51(7):699–705.CrossRef
49.
go back to reference Kim S, Chang Y, Sung E, Kim CH, Yun KE, Jung H-S, et al. Non-alcoholic fatty liver disease and the development of nephrolithiasis: a cohort study. PLoS ONE. 2017;12(10):e0184506.CrossRef Kim S, Chang Y, Sung E, Kim CH, Yun KE, Jung H-S, et al. Non-alcoholic fatty liver disease and the development of nephrolithiasis: a cohort study. PLoS ONE. 2017;12(10):e0184506.CrossRef
50.
go back to reference Agrawal V, Shah A, Rice C, Franklin BA, McCullough PA. Impact of treating the metabolic syndrome on chronic kidney disease. Nat Rev Nephrol. 2009;5(9):520–8.CrossRef Agrawal V, Shah A, Rice C, Franklin BA, McCullough PA. Impact of treating the metabolic syndrome on chronic kidney disease. Nat Rev Nephrol. 2009;5(9):520–8.CrossRef
51.
go back to reference Einollahi B, Naghii M, Sepandi M. Association of nonalcoholic fatty liver disease (NAFLD) with urolithiasis. Endocr Regul. 2013;47(1):27–32.CrossRef Einollahi B, Naghii M, Sepandi M. Association of nonalcoholic fatty liver disease (NAFLD) with urolithiasis. Endocr Regul. 2013;47(1):27–32.CrossRef
52.
go back to reference Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med Overseas Ed. 2010;363(14):1341–50.CrossRef Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med Overseas Ed. 2010;363(14):1341–50.CrossRef
53.
go back to reference Wei Y-p, Lin X-g, He R-q, Shen J, Sun S-l, Chen G, et al. Epidemiologic association of nonalcoholic fatty liver disease and urinary calculi: a population-based cross-sectional study in southern China. Iran J Kidney Dis. 2018;12(2):112–9. Wei Y-p, Lin X-g, He R-q, Shen J, Sun S-l, Chen G, et al. Epidemiologic association of nonalcoholic fatty liver disease and urinary calculi: a population-based cross-sectional study in southern China. Iran J Kidney Dis. 2018;12(2):112–9.
54.
go back to reference Zeina A-R, Goldenberg L, Nachtigal A, Hasadia R, Saliba W. Association between nephrolithiasis and fatty liver detected on non-enhanced CT for clinically suspected renal colic. Clin Imaging. 2017;43:148–52.CrossRef Zeina A-R, Goldenberg L, Nachtigal A, Hasadia R, Saliba W. Association between nephrolithiasis and fatty liver detected on non-enhanced CT for clinically suspected renal colic. Clin Imaging. 2017;43:148–52.CrossRef
55.
go back to reference Mitra P, Pal DK, Das M. Does quality of drinking water matter in kidney stone disease: a study in West Bengal. India Investig Clin Urol. 2018;59(3):158–65.CrossRef Mitra P, Pal DK, Das M. Does quality of drinking water matter in kidney stone disease: a study in West Bengal. India Investig Clin Urol. 2018;59(3):158–65.CrossRef
56.
go back to reference Basiri A, Shakhssalim N, Khoshdel AR, Ghahestani SM, Basiri HJIu. The demographic profile of urolithiasis in Iran: a nationwide epidemiologic study. Int Urol Nephrol. 2010;42(1):119–26.CrossRef Basiri A, Shakhssalim N, Khoshdel AR, Ghahestani SM, Basiri HJIu. The demographic profile of urolithiasis in Iran: a nationwide epidemiologic study. Int Urol Nephrol. 2010;42(1):119–26.CrossRef
57.
go back to reference Abufaraj M, Xu T, Cao C, Waldhoer T, Seitz C, D’andrea D, et al. Prevalence and trends in kidney stone among adults in the USA: analyses of national health and nutrition examination survey 2007–2018 data. Eur Urol Focus. 2021;7(6):1468–75.CrossRef Abufaraj M, Xu T, Cao C, Waldhoer T, Seitz C, D’andrea D, et al. Prevalence and trends in kidney stone among adults in the USA: analyses of national health and nutrition examination survey 2007–2018 data. Eur Urol Focus. 2021;7(6):1468–75.CrossRef
58.
go back to reference Okada A, Hamamoto S, Taguchi K, Unno R, Sugino T, Ando R, et al. Kidney stone formers have more renal parenchymal crystals than non-stone formers, particularly in the papilla region. BMC Urol. 2018;18(1):1–10.CrossRef Okada A, Hamamoto S, Taguchi K, Unno R, Sugino T, Ando R, et al. Kidney stone formers have more renal parenchymal crystals than non-stone formers, particularly in the papilla region. BMC Urol. 2018;18(1):1–10.CrossRef
59.
go back to reference Słojewski M, Czerny B, Safranow K, Droździk M, Pawlik A, Jakubowska K, et al. Does smoking have any effect on urinary stone composition and the distribution of trace elements in urine and stones? Urol Res. 2009;37(6):317–22.CrossRef Słojewski M, Czerny B, Safranow K, Droździk M, Pawlik A, Jakubowska K, et al. Does smoking have any effect on urinary stone composition and the distribution of trace elements in urine and stones? Urol Res. 2009;37(6):317–22.CrossRef
60.
go back to reference Liu CC, Huang SP, Wu WJ, Chou YH, Juo SH, Tsai LY, et al. The impact of cigarette smoking, alcohol drinking and betel quid chewing on the risk of calcium urolithiasis. Ann Epidemiol. 2009;19(8):539–45.CrossRef Liu CC, Huang SP, Wu WJ, Chou YH, Juo SH, Tsai LY, et al. The impact of cigarette smoking, alcohol drinking and betel quid chewing on the risk of calcium urolithiasis. Ann Epidemiol. 2009;19(8):539–45.CrossRef
61.
go back to reference Soueidan M, Bartlett SJ, Noureldin YA, Andersen RE, Andonian S. Leisure time physical activity, smoking and risk of recent symptomatic urolithiasis: survey of stone clinic patients. Can Urol Assoc J. 2015;9(7–8):257.CrossRef Soueidan M, Bartlett SJ, Noureldin YA, Andersen RE, Andonian S. Leisure time physical activity, smoking and risk of recent symptomatic urolithiasis: survey of stone clinic patients. Can Urol Assoc J. 2015;9(7–8):257.CrossRef
62.
go back to reference Tamadon MR, Nassaji M, Ghorbani R. Cigarette smoking and nephrolitiasis in adult individuals. Nephro-Urol Month. 2013;5(1):702–5.CrossRef Tamadon MR, Nassaji M, Ghorbani R. Cigarette smoking and nephrolitiasis in adult individuals. Nephro-Urol Month. 2013;5(1):702–5.CrossRef
63.
go back to reference Sofia HN, et al. Prevalence and risk factors of kidney stone. Glob J Res Anal. 2016;5:183–7. Sofia HN, et al. Prevalence and risk factors of kidney stone. Glob J Res Anal. 2016;5:183–7.
64.
go back to reference Ferraro PM, Curhan GC, Sorensen MD, Gambaro G, Taylor EN. Physical activity, energy intake and the risk of incident kidney stones. J Urol. 2015;193(3):864–8.CrossRef Ferraro PM, Curhan GC, Sorensen MD, Gambaro G, Taylor EN. Physical activity, energy intake and the risk of incident kidney stones. J Urol. 2015;193(3):864–8.CrossRef
65.
go back to reference Meschi T, Schianchi T, Ridolo E, Adorni G, Allegri F, Guerra A, et al. Body weight, diet and water intake in preventing stone disease. Urol Int. 2004;72(Suppl 1):29–33.CrossRef Meschi T, Schianchi T, Ridolo E, Adorni G, Allegri F, Guerra A, et al. Body weight, diet and water intake in preventing stone disease. Urol Int. 2004;72(Suppl 1):29–33.CrossRef
Metadata
Title
Prevalence and risk factors of kidney stone disease in population aged 40–70 years old in Kharameh cohort study: a cross-sectional population-based study in southern Iran
Authors
Leila Moftakhar
Fatemeh Jafari
Masoumeh Ghoddusi Johari
Ramin Rezaeianzadeh
Seyed Vahid Hosseini
Abbas Rezaianzadeh
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Fatty Liver
Published in
BMC Urology / Issue 1/2022
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-022-01161-x

Other articles of this Issue 1/2022

BMC Urology 1/2022 Go to the issue